Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk (Q28202563)

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914066-4

7 January 2021

Coagulation activation following estrogen administration to postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914066-4

7 January 2021

Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914066-4

7 January 2021

Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914066-4

7 January 2021

Risk of venous thromboembolism in users of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914066-4

7 January 2021

Prospective study of exogenous hormones and risk of pulmonary embolism in women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914066-4

7 January 2021

Hormone replacement therapy and risk of venous thromboembolism: population based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914066-4

7 January 2021

Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population-based study in southern Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914066-4

7 January 2021

Hormone Replacement Therapy with Estradiol and Risk of Venous Thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914066-4

7 January 2021

Evidence from randomised trials on the long-term effects of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914066-4

7 January 2021

Assessment of the risk for venous thromboembolism among users of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914066-4

7 January 2021

Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914066-4

7 January 2021

Case-control studies in the evaluation of drug-induced illness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914066-4

7 January 2021

Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914066-4

7 January 2021

Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914066-4

7 January 2021

Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β-estradiol: Comparison with conventional oral estrogens used for hormone replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914066-4

7 January 2021

Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914066-4

7 January 2021

Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914066-4

7 January 2021

Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914066-4

7 January 2021

Hormone replacement therapy and screening mammography: analysis of the results in the Bouches du Rhône programme

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914066-4

7 January 2021

Hormone replacement therapy use is associated with a lower occurrence of carotid atherosclerotic plaques but not with intima-media thickness progression among postmenopausal women. The vascular aging (EVA) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914066-4

7 January 2021